BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4804290)

  • 1. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
    Martin WJ; Esber E; Cotton WG; Rice JM
    J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR; Cerottini JC; Brunner KT
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies specific for the theta- and Ly-alloantigens in various rabbit antisera.
    Rabinowitz R; Cohen A; Laskov R; Schlesinger M
    J Immunol; 1974 Feb; 112(2):683-92. PubMed ID: 4405954
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.
    Goldberg EH; Tokuda S
    Transplant Proc; 1977 Jun; 9(2):1363-5. PubMed ID: 878010
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of a clonal assay for cytotoxic T lymphocytes to determine the Ly phenotypes of the cytotoxic precursor and effector cells to alloantigens and trinitrophenyl-modified self antigens.
    Teh HS; Teh SJ
    J Immunol; 1980 Nov; 125(5):1977-86. PubMed ID: 6159396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of lymphoid cell cytotoxicity, shown in vitro, of mice bearing a syngeneic tumor after injection of killed tumor cells].
    Lafontaine N; Firket H
    C R Seances Soc Biol Fil; 1975; 169(2):456-8. PubMed ID: 126787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple composition of foreign alloantigens on a murine fibrosarcoma [proceedings].
    Invernizzi G; Carbone G; Parmiana G
    Folia Biol (Praha); 1976; 22(6):393-4. PubMed ID: 1001559
    [No Abstract]   [Full Text] [Related]  

  • 12. Facilitation of metastasis by antithymocyte globulin.
    James SE; Salsbury AJ
    Cancer Res; 1974 Feb; 34(2):367-70. PubMed ID: 4544019
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between Fc (IgG) receptors and alloantigens on the surface of BALB/c B cell lymphoma lines.
    Kanellopoulos-Langevin C; Kim KJ; Sachs DH; Asofsky R
    J Immunol; 1979 Dec; 123(6):2651-7. PubMed ID: 501085
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro recognition of alloantigens: nature of responding and stimulating cells.
    Berman M; Puryear K; Argyris BF
    Cell Immunol; 1976 Apr; 23(1):126-39. PubMed ID: 131649
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
    Alley CD; Snodgrass MJ
    Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
    [No Abstract]   [Full Text] [Related]  

  • 18. The histological response to a xenogeneic tumour in mice.
    Simpson E; Beverley PC
    Clin Exp Immunol; 1973 Jul; 14(3):443-55. PubMed ID: 4725398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of cellular immunity against urethan-induced lung adenomas of mice.
    Colnaghi MI; Ménard S; Porta GD
    J Natl Cancer Inst; 1971 Dec; 47(6):1325-31. PubMed ID: 5120411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.